Abarceo Pharma
Abarceo Pharma is a spin out of Lund University Diabetes Center. The company is dedicated to developing novel therapeutics for type-2 diabetes based upon a deep molecular and genetic understanding of the disease.Abarceo Pharma has identified a novel diabetes target and has elucidated the key to the revival of dysfunctional beta cells enabling a resetting of the beta cell to a functional and health
https://www.innovation.lu.se/en/abarceo-pharma - 2025-08-05